Jonathan Mercer Watkins
Corporate Officer/Principal presso University of Birmingham
Posizioni attive di Jonathan Mercer Watkins
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Birmingham | Corporate Officer/Principal | - | - |
Storia della carriera di Jonathan Mercer Watkins
Precedenti posizioni note di Jonathan Mercer Watkins
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
